Filings monitor · CLX

What CLOROX CO /DE/'s SEC filings said

10-Q for 2026Q3, filed 2 Nov 2026, and 1 8-K since. Each line is something a filing stated, ranked by score and linked to its source.

Ranked highest

1. Acquisition / Partnership / Divestiture91 · importance in its document · 10-Q · 2026Q3
   Clorox’s GOJO acquisition, whose business operates as Clorox Purell ProCare, contributed to year-over-year sales and volume growth in the quarter ended September 30, 2026. The company reported $1,175 million of notes and loans payable,…
2. Debt and Liquidity Position89 · importance in its document · 8-K exhibit · 2 Nov 2026
   At September 30, 2026, Clorox reported $184 million of cash and cash equivalents, compared with $166 million at September 30, 2025. Notes and loans payable were $1.175 billion, and long-term debt was $3.982 billion, for total reported…
3. Revenue Performance and Mix70 · importance in its document · 10-Q · 2026Q3
   For the three months ended September 30, 2026, consolidated net sales increased 33% year over year to $1,905 million, compared with $1,429 million. The increase reflected a 31% rise in volume, lapping lower prior-year shipments after the…
4. Health and Wellness Demand69 · importance in its document · 10-Q · 2026Q3
   Health and Wellness volume and net sales increased 55% and 62%, respectively, while segment adjusted EBIT increased 69%. The volume increase reflected the GOJO acquisition and comparison with lower shipments in the prior-year period…
5. Liquidity and Debt Position64 · importance in its document · 10-Q · 2026Q3
   At September 30, 2026, Clorox had approximately $1,175 million of notes and loans payable, primarily U.S. commercial paper used to fund the GOJO acquisition and a Venture Agreement termination payment. Current liabilities exceeded current…

Ranked by score, 0–100. A topic read from a document carries its importance within that document; an 8-K event carries the rule score that ranks a filing among filings. Neither is about the share price, and the two scales are named on each row because they are not the same measure.

Latest report: 10-Q · 2026Q3 filed 2 Nov 2026

Full report · Filing on EDGAR

• Acquisition / Partnership / DivestitureImportance 91
  Clorox’s GOJO acquisition, whose business operates as Clorox Purell ProCare, contributed to year-over-year sales and volume growth in the quarter ended September 30, 2026. The company reported $1,175 million of notes…
• Revenue Performance and MixImportance 70
  For the three months ended September 30, 2026, consolidated net sales increased 33% year over year to $1,905 million, compared with $1,429 million. The increase reflected a 31% rise in volume, lapping lower prior-year…
• Health and Wellness DemandImportance 69 · +3 more on this subject
  Health and Wellness volume and net sales increased 55% and 62%, respectively, while segment adjusted EBIT increased 69%. The volume increase reflected the GOJO acquisition and comparison with lower shipments in the…
• Liquidity and Debt PositionImportance 64
  At September 30, 2026, Clorox had approximately $1,175 million of notes and loans payable, primarily U.S. commercial paper used to fund the GOJO acquisition and a Venture Agreement termination payment. Current…
• Operating Cash Flow TrendsImportance 63
  Net cash provided by operations was $143 million in the three months ended September 30, 2026, compared with $93 million in the prior-year quarter, an increase of approximately 54%. Higher cash earnings drove the…
• Net Income and EPS PerformanceImportance 50
  Diluted earnings per share rose $0.74, from $0.65 to $1.39, in the three months ended September 30, 2026, an increase of 114% year over year. Higher net sales and cost savings drove the increase, partly offset by…
• Income Tax Rate ChangesImportance 40
  The effective tax rate on earnings declined to 16.4% in the three months ended September 30, 2026, from 23.4% in the prior-year quarter, a decrease of 7.0 percentage points. Clorox attributed the lower rate primarily…
• Share Repurchase ProgramImportance 38
  Clorox had an open-market repurchase authorization of up to $2,000 million with no expiration date, as well as an Evergreen Program to offset anticipated dilution from stock-based awards. The company repurchased no…
• Trade Policy and TariffsImportance 32
  The company says U.S. trade policies continue to evolve, including new or increased tariffs on product imports from certain countries. It says these tariffs, potential additional tariffs and retaliatory measures have…
• Guidance / OutlookImportance 26
  For fiscal year 2027, Clorox anticipates a volatile and challenging operating environment as continued macroeconomic uncertainty may put greater pressure on consumers’ spending. Management says it will continue…
• Margin DriversImportance 24
  Gross margin declined 130 basis points year over year, from 41.7% to 40.4%, in the three months ended September 30, 2026. Higher commodity costs and higher manufacturing and logistics costs drove the decline, partly…
• Macroeconomic Consumer PressureImportance 20
  Clorox says consumers continue to feel pressure as macroeconomic uncertainty affects spending and prices remain elevated. For fiscal year 2027, the company expects a volatile and challenging operating environment, with…

8-K filings last 12 months

• Guidance revised (direction not stated)2 Nov 2026 · 8-K Item 2.02 · Flagged · rule score 55
  “Clorox Reports Q1 Fiscal Year 2027 Results, Updates Outlook OAKLAND, Calif., Nov. 2, 2026 — The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2027, which ended Sept. 30, 2026.”
  Read from the attached exhibit: Debt and Liquidity Position · Acquisition / Partnership / Divestiture · Segment Revenue Performance
• New CEO named29 Oct 2026 · 8-K Item 5.02 · Flagged · rule score 55
  “On October 28, 2026, the Board of Directors (the “Board”) of The Clorox Company (the “Company”), appointed Fabian Garcia to serve as the Chief Executive Officer (“CEO”) of the Company and a member of the Board, effective as of January 5,…”
• Results (release not read)3 Aug 2026 · 8-K Item 2.02 · Routine · rule score 20
• Management change (filing not read)17 Jun 2026 · 8-K Item 5.02 · Routine · rule score 20
• Management change (filing not read)28 May 2026 · 8-K Item 5.02 · Routine · rule score 20
• Results (release not read)30 Apr 2026 · 8-K Item 2.02 · Routine · rule score 20
• New debt10 Mar 2026 · 8-K Items 1.01, 2.03 · Routine · rule score 25
• Results (release not read)3 Feb 2026 · 8-K Item 2.02 · Routine · rule score 20

Earlier reports

• 10-K · 2026filed 7 Aug 2026
  Acquisition / Partnership / Divestiture · Technology Transformation

Topics are read from the text of the 10-K, 10-Q or the exhibit attached to an 8-K, each linked to the passage it came from. 8-K events are labelled by fixed rules from the item codes and the filing text — the same rules for every company and every year. The Full Picture merges these with earnings calls and news.